INTELLIGENT BIO SOLUTIONS INC. Operating Expenses
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Operating Expenses of $15.34 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. operating expenses for the quarter ending 2026-06-30 was $4.75M, a 24.19% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. operating expenses for the quarter ending 2026-03-31 was $3.65M, a 18.64% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. operating expenses for the quarter ending 2025-12-31 was $3.17M, a 20.87% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. operating expenses for the quarter ending 2025-09-30 was $3.71M, a 16.04% increase year-over-year.
- INTELLIGENT BIO SOLUTIONS INC. operating expenses for fiscal 2026 was $15.34M, a 20.35% increase from fiscal 2025.
- INTELLIGENT BIO SOLUTIONS INC. operating expenses for fiscal 2025 was $12.74M, a 5.02% increase from fiscal 2024.
- INTELLIGENT BIO SOLUTIONS INC. operating expenses for fiscal 2024 was $12.13M, a 11.17% decline from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. operating expenses for fiscal 2023 was $13.66M, a 55.68% increase from fiscal 2022.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month | Operating Expenses 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $8.40M derived: sum of 2 quarters · filed 2026-08-19 | $11.57M derived: sum of 3 quarters · filed 2026-08-19 | $15.34M 10-K · filed 2026-08-19 | |||
| 2026-03-31 | $3.65M 10-Q · filed 2026-05-13 | $6.82M derived: sum of 2 quarters · filed 2026-05-13 | $10.58M 10-Q · filed 2026-05-13 | $14.35M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-12-31 | $3.17M 10-Q · filed 2026-02-12 | $6.88M 10-Q · filed 2026-02-12 | $10.71M derived: sum of 3 quarters · filed 2026-08-19 | $13.78M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-09-30 | $3.71M 10-Q · filed 2025-11-12 | $7.54M derived: sum of 2 quarters · filed 2026-08-19 | $10.61M derived: sum of 3 quarters · filed 2026-08-19 | $13.23M derived: sum of 4 quarters · filed 2026-08-19 | |||
| 2025-06-30 | $3.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | $6.90M derived: sum of 2 quarters · filed 2026-08-19 | $9.52M derived: sum of 3 quarters · filed 2026-08-19 | $12.74M 10-K · filed 2026-08-19 | $12.71M 10-K · filed 2025-08-15 | ||
| 2025-03-31 | $3.07M 10-Q · filed 2026-05-13 | $3.07M 10-Q · filed 2025-05-13 | $5.70M derived: sum of 2 quarters · filed 2026-05-13 | $8.92M 10-Q · filed 2026-05-13 | $8.89M 10-Q · filed 2025-05-13 | $12.60M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $2.62M 10-Q · filed 2026-02-12 | $5.82M 10-Q · filed 2026-02-12 | $9.52M derived: sum of 3 quarters · filed 2026-02-12 | $12.74M derived: sum of 4 quarters · filed 2026-02-12 | |||
| 2024-09-30 | $3.20M 10-Q · filed 2025-11-12 | $6.90M derived: sum of 2 quarters · filed 2025-11-12 | $10.12M derived: sum of 3 quarters · filed 2025-11-12 | $12.46M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | $6.92M derived: sum of 2 quarters · filed 2025-08-15 | $9.27M derived: sum of 3 quarters · filed 2025-08-15 | $12.13M 10-K · filed 2025-08-15 | |||
| 2024-03-31 | $3.22M 10-Q · filed 2025-05-13 | $5.56M derived: sum of 2 quarters · filed 2025-05-13 | $8.43M 10-Q · filed 2025-05-13 | $11.22M derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | $2.34M 10-Q · filed 2025-02-13 | $5.21M 10-Q · filed 2025-02-13 | $8.00M derived: sum of 3 quarters · filed 2025-02-13 | $14.70M derived: sum of 4 quarters · filed 2025-02-13 | |||
| 2023-09-30 | $2.87M 10-Q · filed 2024-11-07 | $5.66M derived: sum of 2 quarters · filed 2024-11-07 | $12.35M derived: sum of 3 quarters · filed 2024-11-07 | $15.00M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $9.49M derived: sum of 2 quarters · filed 2024-09-18 | $12.13M derived: sum of 3 quarters · filed 2024-09-18 | $13.66M 10-K · filed 2024-09-18 | |||
| 2023-03-31 | $6.69M 10-Q · filed 2024-05-08 | $9.34M derived: sum of 2 quarters · filed 2024-05-08 | $10.87M 10-Q · filed 2024-05-08 | $13.02M derived: sum of 4 quarters · filed 2024-05-08 | |||
| 2022-12-31 | $2.64M 10-Q · filed 2024-02-09 | $4.17M 10-Q · filed 2024-02-09 | $6.33M derived: sum of 3 quarters · filed 2024-02-09 | $7.86M derived: sum of 4 quarters · filed 2024-02-09 | |||
| 2022-09-30 | $1.53M 10-Q · filed 2023-11-08 | $3.68M derived: sum of 2 quarters · filed 2023-11-08 | $5.22M derived: sum of 3 quarters · filed 2023-11-08 | $8.86M derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $2.15M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | $3.69M derived: sum of 2 quarters · filed 2023-08-23 | $7.33M derived: sum of 3 quarters · filed 2023-08-23 | $8.77M 10-K · filed 2023-08-23 | |||
| 2022-03-31 | $1.54M 10-Q · filed 2023-05-11 | $5.18M derived: sum of 2 quarters · filed 2023-05-11 | $6.62M 10-Q · filed 2023-05-11 | $9.08M derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | $3.64M 10-Q · filed 2023-02-14 | $5.08M 10-Q · filed 2023-02-14 | $7.54M derived: sum of 3 quarters · filed 2023-02-14 | $10.72M derived: sum of 4 quarters · filed 2023-02-14 | |||
| 2021-09-30 | $1.44M 10-Q · filed 2022-11-14 | $3.90M derived: sum of 2 quarters · filed 2022-11-14 | $7.07M derived: sum of 3 quarters · filed 2022-11-14 | $8.27M derived: sum of 4 quarters · filed 2022-11-14 | |||
| 2021-06-30 | $2.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-22 | $5.64M derived: sum of 2 quarters · filed 2022-09-22 | $6.84M derived: sum of 3 quarters · filed 2022-09-22 | $7.55M 10-K · filed 2022-09-22 | |||
| 2021-03-31 | $3.17M 10-Q · filed 2022-05-16 | $4.38M derived: sum of 2 quarters · filed 2022-05-16 | $5.09M 10-Q · filed 2022-05-16 | $5.67M derived: sum of 4 quarters · filed 2022-05-16 | |||
| 2020-12-31 | $1.20M 10-Q · filed 2022-02-11 | $1.92M 10-Q · filed 2022-02-11 | $2.50M derived: sum of 3 quarters · filed 2022-02-11 | $2.52M derived: sum of 4 quarters · filed 2022-02-11 | |||
| 2020-09-30 | $718.42K 10-Q · filed 2021-11-12 | $1.30M derived: sum of 2 quarters · filed 2021-11-12 | $1.32M derived: sum of 3 quarters · filed 2021-11-12 | $3.03M derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | $577.89K derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $605.18K derived: sum of 2 quarters · filed 2021-09-16 | $2.31M derived: sum of 3 quarters · filed 2021-09-16 | $3.05M 10-K · filed 2021-09-16 | |||
| 2020-03-31 | $27.29K 10-Q · filed 2021-05-13 | $1.73M derived: sum of 2 quarters · filed 2021-05-13 | $2.47M 10-Q · filed 2021-05-13 | ||||
| 2019-12-31 | $1.70M 10-Q · filed 2021-02-12 | $2.44M 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |